Lv6
1688 积分 2022-06-16 加入
On the road to in vivo CAR-T success: Comparing promising viral and non-viral vectors
14天前
已完结
Antigen identification and high-throughput interaction mapping by reprogramming viral entry
14天前
已完结
Engineering in vivo CAR-T cells
15天前
已完结
In vivo CAR T cell engineering: design principles and open questions
23天前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
1个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
1个月前
已完结
In vivo CAR T cells move into clinical trials
2个月前
已完结
Lipid nanoparticles produce chimeric antigen receptor T cells with interleukin-6 knockdown in vivo
2个月前
已完结
Therapy with CD7 monoclonal antibody TH‐69 is highly effective for xenografted human T‐cell ALL
2个月前
已完结
Lipid nanoparticle–mediated in vivo generation of panCAR immune cells for solid tumor immunotherapy
2个月前
已完结
皖公网安备34019202002308
